Vernal keratoconjunctivitis VKC 50 scholarly articles free access

Vernal keratoconjunctivitis (VKC) or Spring catarrh is a recurrent, bilateral, and self limiting inflammation of conjunctiva, having a periodic seasonal incidence.

1.    Images in clinical medicine. Vernal keratoconjunctivitis.

Homme J, Wiswell J.

N Engl J Med. 2012 Feb 16;366(7):647. No abstract available.

2.    Direct fluorescent antibody assay and polymerase chain reaction for the detection of Chlamydia trachomatis in patients with vernal keratoconjunctivitis.

Nishiwaki-Dantas MC, de Abreu MT, de Melo CM, Romero IL, Neto RB, Dantas PE.

Clinics (Sao Paulo). 2011;66(12):2013-8.

3.    A clinical study to assess the efficacy of Triyushnadi Anjana in Kaphaja Abhishyanda with special reference to vernal keratoconjunctivitis.

Dhiman KS, Sharma G, Singh S.

Ayu. 2010 Oct;31(4):466-72.

4.    Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series.

Taddio A, Cimaz R, Caputo R, de Libero C, Di Grande L, Simonini G, Mori F, Novembre E, Pucci N.

Pediatr Rheumatol Online J. 2011 Nov 2;9(1):34.

5.    Association of hemopexin in tear film and conjunctival macrophages with vernal keratoconjunctivitis.

Pong JC, Chu CY, Li WY, Tang LY, Li L, Lui WT, Poon TC, Rao SK, Lam DS, Wang CC, Pang CP.

Arch Ophthalmol. 2011 Apr;129(4):453-61.

6.    Are cutaneous hypersensitivity tests to inhalant allergens a severity marker for vernal keratoconjunctivitis?

Augusto de Oliveira L, Mallozi MC, Sole D, Freitas D, Sousa LB, Mannis MJ.

Arq Bras Oftalmol. 2007 Nov-Dec;70(6):991-5.

7.    Conjunctival Inclusion Cysts in Long-standing Chronic Vernal Keratoconjunctivitis.

Lee SW, Lee SC, Jin KH.

Korean J Ophthalmol. 2007 Dec;21(4):251-4.

8.    Natural killer cells in vernal keratoconjunctivitis.

Lambiase A, Normando EM, Vitiello L, Micera A, Sacchetti M, Perrella E, Racioppi L, Bonini S, Bonini S.

Mol Vis. 2007 Aug 30;13:1562-7.

9.    [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].

Doan S, Gabison E, Abitbol O, Gatinel D, Chast F, Hoang-Xuan T.

J Fr Ophtalmol. 2007 Sep;30(7):697-701. French.

10.  Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva.

Micera A, Lambiase A, Stampachiacchiere B, Sgrulletta R, Normando EM, Bonini S, Bonini S.

Mol Vis. 2007 Jun 21;13:981-7.

 

11.  Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.

Mantelli F, Santos MS, Petitti T, Sgrulletta R, Cortes M, Lambiase A, Bonini S.

Br J Ophthalmol. 2007 Dec;91(12):1656-61. Epub 2007 Jun 22. Review.

12.  Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.

Leonardi A, Bremond-Gignac D, Bortolotti M, Violato D, Pouliquen P, Delval L, Grouin JM, Fregona IA.

Br J Ophthalmol. 2007 Dec;91(12):1662-6. Epub 2007 Jun 21.

13.  Vernal keratoconjunctivitis.

Hall A, Shilio B.

Community Eye Health. 2005 Mar;18(53):76-8

14.  [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].

Hida WT, Nogueira DC, Schaefer A, Dantas PE, Dantas MC.

Arq Bras Oftalmol. 2006 Nov-Dec;69(6):851-6. Portuguese.

15.  Conjunctival expression of thymosin-beta4 in vernal keratoconjunctivitis.

Micera A, Bonini S, Lambiase A, Lapucci G, Bonini S, Rasi G.

Mol Vis. 2006 Dec 20;12:1594-600.

16.  Trypsin inhibitory capacity in vernal keratoconjunctivitis.

Ghavami S, Hashemi M, de Serres FJ, Bajestani SN, Mehrabifar H, Leonardi A.

Invest Ophthalmol Vis Sci. 2007 Jan;48(1):264-9.

17.  Vernal keratoconjunctivitis.

Wakefield D, McCluskey PJ.

Med J Aust. 2006 Nov 6;185(9):523. Review. No abstract available.

18.  Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study.

Jain AK, Sukhija J.

Indian J Ophthalmol. 2006 Jun;54(2):111-6.

19.  Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis.

Motterle L, Diebold Y, Enríquez de Salamanca A, Saez V, Garcia-Vazquez C, Stern ME, Calonge M, Leonardi A.

Arch Ophthalmol. 2006 Apr;124(4):462-8.

20.  Vernal keratoconjunctivitis and intestinal parasitic infestations in black children.

Ajaiyeoba A.

J Natl Med Assoc. 2005 Nov;97(11):1529-32.

21.  Topographic corneal changes in patients with vernal keratoconjunctivitis.

Dantas PE, Alves MR, Nishiwaki-Dantas MC.

Arq Bras Oftalmol. 2005 Sep-Oct;68(5):593-8. Epub 2005 Nov 28.

22.  Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.

Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70.

23.  Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis.

Pucci N, Novembre E, Lombardi E, Massai C, Bernardini R, Caputo R, Campa L, de Libero C, Vierucci A.

Pediatrics. 2005 Jan;115(1):e86-91.

24.  Vernal keratoconjunctivitis in Thailand.

Kosrirukvongs P, Vichyanond P, Wongsawad W.

Asian Pac J Allergy Immunol. 2003 Mar;21(1):25-30.

25.  Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis.

Singh S, Pal V, Dhull CS.

Indian J Ophthalmol. 2001 Dec;49(4):241-5.

26.  Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.

Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi AG.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3052-8.

27.  Corneal deposits after the topical use of ofloxacin in two children with vernal keratoconjunctivitis.

Claerhout I, Kestelyn P, Meire F, Remon JP, Decaestecker T, Van Bocxlaer J.

Br J Ophthalmol. 2003 May;87(5):646. No abstract available.

28.  Recurrent shield ulcer following penetrating keratoplasty for keratoconus associated with vernal keratoconjunctivitis.

Garg P, Bansal AK, Sangwan VS.

Indian J Ophthalmol. 2003 Mar;51(1):79-80.

29.  Penicillium keratitis in vernal Keratoconjunctivitis.

Arora R, Gupta S, Raina UK, Mehta DK, Taneja M.

Indian J Ophthalmol. 2002 Sep;50(3):215-6.

30.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

El-Asrar AM, Struyf S, Al-Kharashi SA, Missotten L, Van Damme J, Geboes K.

Br J Ophthalmol. 2002 Oct;86(10):1175-80.

31.  Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis.

Sethi HS, Wangh VB, Rai HK.

Indian J Ophthalmol. 2002 Jun;50(2):160-1; author reply 161. No abstract available.

32.  Expression of chemokine receptors in vernal keratoconjunctivitis.

Abu El-Asrar AM, Struyf S, Al-Mosallam AA, Missotten L, Van Damme J, Geboes K.

Br J Ophthalmol. 2001 Nov;85(11):1357-61.

33.  Growth factors and collagen distribution in vernal keratoconjunctivitis.

Leonardi A, Brun P, Tavolato M, Abatangelo G, Plebani M, Secchi AG.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4175-81.

34.  Chemokines in the limbal form of vernal keratoconjunctivitis.

Abu El-Asrar AM, Struyf S, Al-Kharashi SA, Missotten L, Van Damme J, Geboes K.

Br J Ophthalmol. 2000 Dec;84(12):1360-6.

35.  Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis.

Tabbara KF, al-Kharashi SA.

Br J Ophthalmol. 1999 Feb;83(2):180-4.

36.  [Vernal keratoconjunctivitis in the child. Clinical and complementary study apropos of 22 cases].

Dalens H, Fauquert JL, Chatron P, Beaujon G.

J Fr Ophtalmol. 1998 Aug-Sep;21(7):471-8. French.

37.  Adhesion molecules in vernal keratoconjunctivitis.

Abu el-Asrar AM, Geboes K, al-Kharashi S, Tabbara KF, Missotten L, Desmet V.

Br J Ophthalmol. 1997 Dec;81(12):1099-106.

38.  Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.

Sharma A, Gupta R, Ram J, Gupta A.

Indian J Ophthalmol. 1997 Sep;45(3):177-80.

39.  Increased plasma levels of substance P in vernal keratoconjunctivitis.

Lambiase A, Bonini S, Micera A, Tirassa P, Magrini L, Bonini S, Aloe L.

Invest Ophthalmol Vis Sci. 1997 Sep;38(10):2161-4.

40.  Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.

Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.

Br J Ophthalmol. 1997 Jan;81(1):23-6.

41.  Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis.

Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K.

Clin Exp Immunol. 1995 Nov;102(2):395-8.

42.  Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells.

Lambiase A, Bonini S, Bonini S, Micera A, Magrini L, Bracci-Laudiero L, Aloe L.

Invest Ophthalmol Vis Sci. 1995 Sep;36(10):2127-32.

43.  Collagen types I and III in giant papillae of vernal keratoconjunctivitis.

Leonardi A, Abatangelo G, Cortivo R, Secchi AG.

Br J Ophthalmol. 1995 May;79(5):482-5.

44.  A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

el Hennawi M.

Br J Ophthalmol. 1994 May;78(5):365-9.

45.  Cytological and immunohistochemical study of the limbal form of vernal keratoconjunctivitis by the replica technique.

el Asrar AM, Geboes K, Missotten L, Emarah MH, Maudgal PC, Desmet V.

Br J Ophthalmol. 1987 Nov;71(11):867-72.

46.  Acute hydrops in keratoglobus with vernal keratoconjunctivitis.

Gupta VP, Jain RK, Angra SK.

Indian J Ophthalmol. 1985 Mar-Apr;33(2):121-3. No abstract available.

47.  Extrinsic and idiopathic vernal keratoconjunctivitis? Two cases with dissimilar immunopathology.

Zavaro A, Baryishak YR, Samra Z, Sompolinsky D.

Br J Ophthalmol. 1983 Nov;67(11):742-5.

48.  Vernal keratoconjunctivitis in the black child and its response to therapy.

Dahan E, Appel R.

Br J Ophthalmol. 1983 Oct;67(10):688-92.

49.  Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate.

Baryishak YR, Zavaro A, Monselise M, Samra Z, Sompolinsky D.

Br J Ophthalmol. 1982 Feb;66(2):118-22.

PMID:6800400

50.  Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis.

El Hennawi M.

Br J Ophthalmol. 1980 Jul;64(7):483-6.